Literature DB >> 26086001

Clinical analysis of risk factors contributing to recurrence of pterygium after excision and graft surgery.

Sang Won Ha1, Joon Ho Park1, Im Hee Shin2, Hong Kyun Kim1.   

Abstract

AIM: To find the risk factors related to the reproliferation of the pterygial tissue after excision and graft surgery.
METHODS: Charts of 130 eyes of 130 patients who had pterygial excision from March 2006 to April 2011 were reviewed. Preoperative pterygium morphology, surgical methods, and adjunctive treatments were statistically analyzed for their relationship with recurrence.
RESULTS: During the follow-up period, recurrence was observed in 20 eyes (15.4%). None of the preoperative morphologic features were affected the rate of the recurrence. However, an age < 40y [P =0.085, odds ratio (OR) 3.609, 95% confidence interval (CI) 0.838-15.540] and amniotic membrane graft instead of conjunctival autograft (P =0.002, OR 9.093, 95% CI 2.316-35.698) were statistically significant risk factors for recurrence. Multivariate analysis revealed that intraoperative mitomycin C (MMC) (P=0.072, OR 0.298, 95% CI 0.080-1.115) decreased the rate of recurrence.
CONCLUSION: Younger age is a risk factor for reproliferation of pterygial tissue after excision and amniotic membrane transplantation (AMT) are less effective in preventing recurrence of pterygium after excision based on the comparison between conjunctival autograft and AMT. Intraoperative MMC application and conjunctival autograft reduce recurrence.

Entities:  

Keywords:  amniotic membrane graft; conjunctival autograft; mitomycin C; pterygium recurrence

Year:  2015        PMID: 26086001      PMCID: PMC4458656          DOI: 10.3980/j.issn.2222-3959.2015.03.15

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  22 in total

Review 1.  Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.

Authors:  John Mauro; C Stephen Foster
Journal:  Semin Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.975

2.  Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium.

Authors:  J C Sánchez-Thorin; G Rocha; J B Yelin
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

3.  Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium.

Authors:  Pinnita Prabhasawat; Nattaporn Tesavibul; Kanjana Leelapatranura; Teeranit Phonjan
Journal:  Ophthalmology       Date:  2006-05-26       Impact factor: 12.079

4.  Intra-lesional 5 fluorouracil for the management of recurrent pterygium.

Authors:  D G Said; L A Faraj; M S Elalfy; A Yeung; A Miri; U Fares; A M Otri; I Rahman; S Maharajan; H S Dua
Journal:  Eye (Lond)       Date:  2013-06-28       Impact factor: 3.775

5.  Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision.

Authors:  P Prabhasawat; K Barton; G Burkett; S C Tseng
Journal:  Ophthalmology       Date:  1997-06       Impact factor: 12.079

6.  Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft.

Authors:  Ahmad Kheirkhah; Hassan Hashemi; Mohsen Adelpour; Mojgan Nikdel; Mohammad Bagher Rajabi; Mahmoud Jabbarvand Behrouz
Journal:  Ophthalmology       Date:  2011-12-06       Impact factor: 12.079

7.  Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis.

Authors:  N Di Girolamo; M T Coroneo; D Wakefield
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-08       Impact factor: 4.799

Review 8.  Environmental light and endogenous antioxidants as the main determinants of non-cancer ocular diseases.

Authors:  Sergio C Saccà; Anna Maria Roszkowska; Alberto Izzotti
Journal:  Mutat Res       Date:  2013-01-19       Impact factor: 2.433

9.  Ten-year results of a randomized controlled trial comparing 0.02% mitomycin C and limbal conjunctival autograft in pterygium surgery.

Authors:  Alvin L Young; Mary Ho; Vishal Jhanji; Lulu Lu Cheng
Journal:  Ophthalmology       Date:  2013-07-16       Impact factor: 12.079

10.  The influence of pterygium morphology on fibrin glue conjunctival autografting pterygium surgery.

Authors:  Sekelj Sandra; Janjetovic Zeljka; Vukovic Arar Zeljka; Samardzic Kristian; Aric Ivana
Journal:  Int Ophthalmol       Date:  2013-06-04       Impact factor: 2.031

View more
  12 in total

1.  Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium.

Authors:  Jun Seok Lee; Sang Won Ha; Sung Yu; Gwang Ja Lee; Young Jeung Park
Journal:  Korean J Ophthalmol       Date:  2017-12

2.  Risk factors for pterygium recurrence after limbal-conjunctival autografting: a retrospective, single-centre investigation.

Authors:  Naser Samadi Aidenloo; Qader Motarjemizadeh; Maryam Heidarpanah
Journal:  Jpn J Ophthalmol       Date:  2018-03-16       Impact factor: 2.447

Review 3.  Pterygium: an update on pathophysiology, clinical features, and management.

Authors:  Toktam Shahraki; Amir Arabi; Sepehr Feizi
Journal:  Ther Adv Ophthalmol       Date:  2021-05-31

4.  Intraoperative Fluorescein Staining of Cryopreserved Amniotic Membrane Grafts to Improve Visualization During and After Pterygium Surgery: A Novel Technique.

Authors:  Jenny Ha; J Alberto Martinez; Michael Korchak; Sandra L Cremers
Journal:  Cornea       Date:  2016-03       Impact factor: 2.651

Review 5.  Anti-fibrotic, anti-VEGF or radiotherapy treatments as adjuvants for pterygium excision: a systematic review and network meta-analysis.

Authors:  Wen Zeng; Zengming Liu; Hanjun Dai; Ming Yan; Hong Luo; Min Ke; Xiaojun Cai
Journal:  BMC Ophthalmol       Date:  2017-11-25       Impact factor: 2.209

Review 6.  How to minimize pterygium recurrence rates: clinical perspectives.

Authors:  Raffaele Nuzzi; Federico Tridico
Journal:  Clin Ophthalmol       Date:  2018-11-19

7.  Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study.

Authors:  Mingyang Yin; Hang Li; Yingnan Zhang; Honglei Dai; Fei Luo; Zhiqiang Pan
Journal:  Cornea       Date:  2019-10       Impact factor: 2.651

8.  Low recurrence rate of anchored conjunctival rotation flap technique in pterygium surgery.

Authors:  Dong Ju Kim; Jimmy K Lee; Roy S Chuck; Choul Yong Park
Journal:  BMC Ophthalmol       Date:  2017-10-10       Impact factor: 2.209

9.  Recurrence Rate and Clinical Outcome of Amniotic Membrane Transplantation Combined with Mitomycin C in Pterygium Surgery: Two-Year Follow-Up.

Authors:  Hasan Razmjoo; Seyed-Abolfazl Kashfi; Majid Mirmohammadkhani; Mohsen Pourazizi
Journal:  J Res Pharm Pract       Date:  2020-03-28

10.  Pterygium Pathology: A Prospective Case-Control Study on Tear Film Cytokine Levels.

Authors:  Sara I Van Acker; Michel Haagdorens; Ella Roelant; Jos Rozema; Tine Possemiers; Veerle Van Gerwen; Marie-José Tassignon; Veva De Groot; Sorcha Ní Dhubhghaill; Carina Koppen; Nadia Zakaria
Journal:  Mediators Inflamm       Date:  2019-11-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.